Small Lymphocytic Lymphoma
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating lenalidomide with alvocidib in relapsed or refractory B-cell chronic lymphocytic leukemia and small lymphocytic lym…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating AMD3100 (Plerixafor) in combination with Rituximab in patients with chronic lymphocytic leukemia or small lymphocyt…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies [Phase 2]
A Phase 2 feasibility study evaluating a 60-minute rapid infusion rituximab protocol in patients with indolent or intermediate-grade B-cell …
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974) [Phase 1]
This Phase 1 trial evaluated the combination of dinaciclib and rituximab in patients with chronic lymphocytic leukemia and small lymphocytic…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating rituximab, cyclophosphamide, bortezomib, and dexamethasone in relapsed/refractory low-grade follicular lym…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This ClinicalTrials.gov update reports a terminated phase 1/2 trial evaluating fenretinide with rituximab for B-cell non-Hodgkin lymphomas; …
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas [Phase 2]
Phase 2 trial assessing idelalisib for indolent B-cell non-Hodgkin lymphomas completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL) [Phase 1]
This document reports the termination of a Phase I trial evaluating cyclophosphamide, rituximab, and lenalidomide (CR2) for relapsed/refract…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 safety and tolerability study evaluating the BTK inhibitor PCI-32765 (ibrutinib) in combination with FCR or BR regimens in chronic l…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Imexon for Relapsed Follicular and Aggressive Lymphomas [Phase 2]
Phase 2 clinical trial results for imexon in relapsed follicular lymphoma and various aggressive B-cell lymphomas have been completed with r…
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating a combination of pentostatin, alemtuzumab, and rituximab in relapsed or refractory chronic lymphocytic leukemia or …
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial assessing pentostatin, cyclophosphamide, and rituximab with or without bevacizumab in patients with chronic lymphocytic leukem…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 study evaluating safety and tolerability of XmAb5574 in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma …
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Safety of PCI-32765 in Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
Clinical trial update reporting safety data for the BTK inhibitor ibrutinib (PCI-32765) in patients with chronic lymphocytic leukemia and sm…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating CCI-779 (temsirolimus) in patients with recurrent or refractory B-cell non-Hodgkin lymphoma or chronic l…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating sunitinib in relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma has completed with …
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
This Phase 2 clinical trial update evaluates lenalidomide in previously treated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma.…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial evaluating Triapine (3-AP) in combination with gemcitabine in patients with advanced solid tumors or lymphoma has completed. I…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating decitabine in combination with valproic acid for adults with refractory or relapsed acute myeloid leukemia or previ…
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older [Phase 2]
Phase 2 clinical trial update evaluating lenalidomide as initial treatment in older patients with chronic lymphocytic leukemia; results post…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab with interleukin-12 in several B-cell non-Hodgkin lymphomas. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial of bendamustine plus alemtuzumab in refractory chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated. The…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating Apolizumab in patients with relapsed or refractory chronic lymph…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
A Phase 1 trial evaluating alvocidib (flavopiridol) for chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma [Phase 2]
A terminated Phase 2 trial evaluated FR901228 alone or with Rituximab and Fludarabine in relapsed or refractory low-grade B-cell non-Hodgkin…